Medical Devices Startups

Céfimeca manufactures high-precision orthopedic instruments (ancillaries) and produces complete surgical implants for various joints such as knee, hip, and shoulder, for the medical/orthopedic industry. It operates in small and large production series and maintains a quality system to meet medical regulatory requirements.

1 investor

Celea develops deupirfenidone, a pulmonary therapeutic targeting idiopathic pulmonary fibrosis in partnership with physicians and patient advocacy organizations.

1 investor

Celero Systems is developing an ingestible pill-based platform that monitors cardiac and respiratory vital signs and delivers medication, aiming to monitor, diagnose, and treat life-threatening conditions without wearables or wires. It operates in the digital health and medical device space.

1 investor

Celexor Bio develops monoclonal antibody therapeutics targeting plasmacytoid dendritic cells to treat severe autoimmune and inflammatory disorders by interrupting the inflammatory cascade at its source. The company's lead candidate, CLXR-901, is designed to deplete pathological pDCs and modify disease progression in underserved patient populations.

1 investor

Cell Invent develops human disease models using reprogrammed Alzheimer patient cells to identify new therapeutic approaches for Alzheimer's disease. The company applies proprietary cellular research technology from Lund University to drug discovery and disease modeling for the neurodegenerative disease market.

1 investor

CellaraRx develops Horizen, a platform that uses single-cell RNA sequencing, digital pathology, and AI to help clinicians and drug developers predict patient response to cancer treatments before clinical trial enrollment. The platform identifies tumor resistance mechanisms and tissue drug accessibility to improve patient stratification and trial success rates.

1 investor

CellaVision is a provider of digital hematology microscopy solutions including analyzers, instruments, reagents, and software that automate workflow in hematology laboratories. The company serves clinical and veterinary laboratories globally with digital cell morphology tools to minimize human error and streamline data management.

1 investor

CellBri provides modular, automated cell processing systems for preparing cells for therapeutic applications. The company offers enclosed, turnkey solutions that can automate individual steps or complete workflows, from cell harvesting and separation through expansion and cryopreservation.

1 investor

CellCarta is a contract research organization providing biomarker discovery, assay development, and clinical trial execution services for pharmaceutical companies and biotechs. It offers multi-omic biomarker insights, regulatory-ready data generation, and regulatory support for assay development and IVDR submissions across preclinical and clinical therapeutic programs.

1 investor

The Cell engineers breakthrough medicines using molecular simulation and artificial intelligence to accelerate drug discovery and development.

1 investor

CELLECT develops nanomaterial-embedded menstrual products (tampons and pads) that non-invasively collect and preserve DNA from menstrual blood for screening of HPV, cervical cancer, and STDs. The collection system is compatible with existing diagnostic assays and targets women seeking an at-home alternative to Pap smears, including underserved communities.

1 investor

Cellemedy develops next-generation therapeutic proteins designed to replace conventional antibody treatments in healthcare.

1 investor

Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations. Founded as a spinout from NanoLund and Prof. Lars Montelius's group, the company focuses on commercializing nanofiber cell culture technology.

1 investor

Cellgym develops IHHT/IHT (intermittent hypoxia-hyperoxia) training devices that simulate altitude training by having users breathe alternating oxygen-poor and oxygen-rich air through a mask. Its Cellair product line (Home, Pro, Lounge, and the CE Class IIa medical device One) serves private users, doctors and therapists, longevity and wellness centers, and premium hotels, with manufacturing in Germany.

1 investor

CellMax Life appears to be a diagnostics company, though the page provided only contains a biography of John Sninsky (Chief Scientific Officer) with no explicit company description, products, or business model stated.

1 investor

Cellpurics is a South Korean biotech company focused on stem cell technologies, including large-scale gonadal stem cell cultivation and storage, Real-time PCR-based measurement of mesenchymal stem cell anti-inflammatory capacity, and high-tech companion animal diagnostics. It also provides contract research organization (CRO) services covering in vitro and in vivo drug efficacy evaluation, veterinary drug and medical device clinical trials, GLP toxicity testing, and AI-based drug discovery.

1 investor

CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications. The company serves researchers and clinicians in drug development, cell therapy monitoring, and clinical diagnostics.

1 investor

CellTivity Scientific provides point-of-care biopsy assessment technology to improve cancer diagnosis accuracy and speed. The company aims to reduce diagnostic delays and uncertainty while preparing samples for next-generation sequencing.

1 investor

CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.

1 investor

Cellumed is a South Korean biotech company focused on musculoskeletal medical devices and biological products. It also develops and supplies growth factors and production enzymes used for RNA vaccines and therapeutics.

1 investor

Cellview develops the WRI-1, a widefield non-mydriatic retinal imaging device that captures up to 133° in a single image and auto-stitches up to 200° for retinal periphery screening. The system is designed for eye care professionals to image patients including those with small pupils, cataracts, or other media opacities.

1 investor

Centre for Sight is a network of eye care hospitals across India, offering treatments and surgeries including LASIK, cataract, glaucoma, retina, squint, and keratoconus care. It operates 95+ eye care centres in 30+ cities with a team of ophthalmologists and diagnostic and surgical technology.

1 investor

Centrillion develops high-density DNA chips combined with AI-powered analysis to generate genomic and cellular data at scale for biological research. The platform enables researchers to ask thousands of variant questions in a single assay and decode genomes, cells, and tissues using AI models.

1 investor

Centurion Service Group runs live and timed auctions for surplus and used medical equipment, connecting hospitals, surgery centers, and equipment dealers as sellers with domestic and international buyers. It also provides equipment appraisals, logistics, account management, and financing/leasing options for healthcare systems disposing of or acquiring clinical assets.

1 investor